News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Novartis AG Gets Approval to Market 4 Drugs in Japan
January 21, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Novartis AG said Wednesday it has received approval in Japan to market four drugs to treat asthma, cancer, hypertension and blindness.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Novartis
MORE ON THIS TOPIC
Approvals
AstraZeneca, Daiichi Sankyo Move Enhertu to First-Line Metastatic Breast Cancer
December 16, 2025
·
2 min read
·
Tristan Manalac
FDA
J&J Wins Proactive FDA National Priority Voucher for Multiple Myeloma Combo
December 16, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
Big Pharma Pushes FDA To Decouple Inspections From Drug Approval Applications
December 16, 2025
·
4 min read
·
Nick Paul Taylor
Approvals
Milestone’s Long Regulatory Road Ends in Approval for Cardamyst
December 15, 2025
·
2 min read
·
Tristan Manalac
